26 hasil untuk "Jen-Der Lin"
Menampilkan 1–20 · 0,56 detik · RSS
-
Artikel Jurnal Teks lengkap
Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus.
BACKGROUND: Increased body mass index is related to the incidence of thyroid cancer. However, the presentation and therapeutic outcomes of different thyroid cancers and type 2 diabetes mellitus (DM) have not been studied. This study investigated the effect of type 2 DM on the clinical presentations…
Juga tersedia di: PLOS
-
Artikel Jurnal
Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study
Background: Papillary thyroid carcinoma occasionally presents with concomitant hyperparathyroidism; however, the clinical significance has not been well established. This study aimed to evaluate the long-term cancer prognosis following a multimodality therapy. Methods: We conducted a case-control…
-
Artikel Jurnal Teks lengkap
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
We explored the therapeutic effects of dinaciclib, a cyclin-dependent kinase (CDK) inhibitor, in the treatment of thyroid cancer.Seven cell lines originating from three pathologic types of thyroid cancer (papillary, follicular and anaplastic) were studied. The cytotoxicity of dinaciclib was…
Juga tersedia di: PLOS
-
Artikel Jurnal
Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer
Background. The aims of this study were to analyze the clinical characteristics of SPM in patients with well-differentiated thyroid cancer and to determine the long-term prognosis in patients with double malignancies. Materials and Methods. We retrospectively analyzed 2,864 patients with…
-
Artikel Jurnal
Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV
To investigate the correlation between gender and the clinical presentation of papillary thyroid cancer and the long-term followup results, 435 patients who underwent total or near-total thyroidectomy were enrolled in this study. Among these papillary thyroid cancer patients, 12.2% showed lymph…
-
Artikel Jurnal Teks lengkap
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
BACKGROUND:We evaluated the therapeutic effects of the histone deacetylase inhibitor PXD101 alone and in combination with conventional chemotherapy in treating thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS:We studied eight cell lines from four types of thyroid cancer (papillary, follicular…
Juga tersedia di: PLOS
-
Artikel Jurnal Teks lengkap
Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis.
The aims of this study were to investigate papillary and follicular thyroid carcinomas with bone metastasis in various clinical presentations and to determine the prognostic factors after multimodality treatment. A retrospective analysis was performed of 3,120 patients with papillary and follicular…
Juga tersedia di: PLOS
-
Artikel Jurnal
Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma
The follicular variant of papillary thyroid carcinoma (FVPTC) is the most common variant of papillary thyroid carcinoma (PTC). A previous population-based study revealed its clinical behavior as a mix of classic papillary thyroid carcinoma (C-PTC) and follicular thyroid carcinoma. Whereas…
-
Artikel Jurnal
Prognostic Evaluation of Patients With Multicentric Papillary Thyroid Microcarcinoma
Patients with papillary thyroid microcarcinoma (PTMC) often have an excellent prognosis. We hypothesize that patients with multicentric PTMC are associated with good clinical outcome, although multicentricity in papillary thyroid carcinoma may be associated with poor prognosis. Methods…
-
Artikel Jurnal Teks lengkap
Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy.
BACKGROUND: We assessed the utility of the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) as single agent therapy and in combination with conventional chemotherapy for thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS: Eight cell lines from four types of thyroid cancer (papillary, follicular…
Juga tersedia di: PLOS
-
Artikel Jurnal
Prognosis of Multifocal Papillary Thyroid Carcinoma
This study was to investigate the clinical features and therapeutic outcomes of multifocal papillary thyroid microcarcinoma (PTMC). A total of 2,418 papillary thyroid carcinoma (PTC) patients had undergone thyroidectomy in one medical center between 1977 and 2010. There were 483 (20.0%) diagnosed…
-
Artikel Jurnal
Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
A retrospective review of 626 patients with multifocal papillary thyroid carcinoma (PTC) including 147 patients (23.5%) with multifocal papillary thyroid microcarcinoma (PTMC) from a total of 2,536 patients with PTC who visited the Chang Gung Medical Center in Linkou, Taiwan, was performed. A…
-
Artikel Jurnal
Subclinical hypothyroidism and metabolic risk factors association: A health examination-based study in northern Taiwan
Background: Subclinical hypothyroidism (SCH) is defined as elevation in serum thyroid-stimulating hormone (TSH) levels despite normal serum levels of free thyroxine. It remains controversial whether people with SCH have higher total cholesterol and low-density lipoprotein cholesterol levels…